Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
OXYGENTAPH Stock Analysis
Views
Red Flags
Positive
Strong revenue growth and above median growth of industry
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis
Weak price momentum
Low and declining operating margin
Low EPS growth and lower than median growth of industry
Low dividend yield
Neutral
Company's earnings are of moderate quality
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.081825.
Snapshot
See detailed analysis
OXYGENTAPH Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
OXYGENTAPH Bulk, Block & Insider Trades
OXYGENTAPH Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No dividend events found
No capital change events found
Company Profile
Oxygenta Pharmaceutical Limited is an India-based company engaged in the manufacturing and selling of pharmaceutical, medical and veterinary preparations. It operates in the pharmaceutical segment. The Company also sells the products to its related companies engaged in the manufacture of formulation... Read More
Key personnel
Dr. Sai Sudhakar VankineniD
Chairman of the Board
Mr. Prasad Reddy Battinapatla
Chief Financial Officer
Ms. Kumkum Bajaj
Compliance Officer, Company Secretary
Mr. Chandra Mouliswar Reddy GangavaramD
Executive Director
Mr. Balasubba Reddy MamillaD
Executive Director
Mrs. Vedavathi GangavaramD
Non-Executive Director
Mr. Veera Reddy AravaD
Non-Executive Independent Director
Mr. Sidda Reddy KanuparthiD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Oxygenta Pharmaceutical Ltd.?
The current share price of Oxygenta Pharmaceutical Ltd. is ₹ 53.78 as of 09 Jan 2026.
What is the PE ratio of Oxygenta Pharmaceutical Ltd.?
The Price-to-Earnings (PE) ratio of Oxygenta Pharmaceutical Ltd. is - as of the latest financial data.
What is the ROE and ROCE of Oxygenta Pharmaceutical Ltd.?
Oxygenta Pharmaceutical Ltd. has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of -49.34% as per the latest financial reports.
What is the market cap of Oxygenta Pharmaceutical Ltd.?
The market capitalization of Oxygenta Pharmaceutical Ltd. stands at ₹ 190.83 Cr.
What is the dividend yield of Oxygenta Pharmaceutical Ltd.?
The dividend yield of Oxygenta Pharmaceutical Ltd. is 0.00% based on the current market price.
What is the RSI of Oxygenta Pharmaceutical Ltd.?
The Relative Strength Index (RSI) of Oxygenta Pharmaceutical Ltd. is 40.20.
What is the FII and DII holding in Oxygenta Pharmaceutical Ltd.?
Foreign Institutional Investors (FII) hold 0.00% and Domestic Institutional Investors (DII) hold 0.03% of Oxygenta Pharmaceutical Ltd. shares.
What sector does Oxygenta Pharmaceutical Ltd. belong to?
Oxygenta Pharmaceutical Ltd. operates in the Healthcare sector.
What is the beta of Oxygenta Pharmaceutical Ltd. stock?
The beta of Oxygenta Pharmaceutical Ltd. stock is 0.87, indicating its volatility relative to the broader market.
